Form 4: Integer Holdings Director Aaron Kapito Awarded RSUs
Statement of Changes in Beneficial Ownership
Director Aaron Kapito received a grant of 1,967 restricted stock units as part of his compensation, increasing his total stake in Integer Holdings Corp.
Summary
- Aaron Kapito, a Director at Integer Holdings Corp (ITGR), was granted 1,967 Restricted Stock Units (RSUs) on May 20, 2026.
- The RSUs convert to common stock on a one-for-one basis upon vesting.
- The grant was issued at a price of $0.00 per share as part of director compensation.
- Following this transaction, Kapito's total beneficial ownership in the company stands at 3,337.677 shares.
- The award is scheduled to vest in four quarterly installments through May 18, 2027.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine and neutral administrative event that confirms standard corporate governance and insider alignment.
Positives
- Increases insider ownership, aligning director interests with those of shareholders.
- The director's total shareholding increased by approximately 143% following this grant.
- Structured vesting schedule ensures long-term commitment from the board member.
Negatives
- Represents potential future dilution for existing shareholders as units vest and convert to common stock.
Risks
- The ultimate value of the compensation is subject to market price fluctuations of ITGR common stock over the vesting period.
Future Outlook
The reporting person will continue to vest in these equity awards over the next twelve months, contingent upon continued service on the board of directors.
Industry Context
StockSavvy.ai notes that equity-heavy compensation for directors is a standard practice among mid-cap medical technology firms to preserve cash while ensuring board members are incentivized to drive share price appreciation.
Comparison to Industry Standards
- The 1,967 unit grant is consistent with annual equity retainers for directors in the medical device sector.
- A one-year quarterly vesting schedule is a common benchmark for non-employee director equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of restricted stock units to a non-employee director as part of the annual compensation program. | 2026-05-20 | Maintains alignment between board members and shareholders. |
Related Party Transactions
- The issuance of equity to a director is a standard related party transaction disclosed under Section 16 of the Securities Exchange Act.
Stakeholder Impact
- Shareholders: Experience minor dilution but benefit from a board incentivized by stock performance.
Next Steps
- Vesting of the first tranche of RSUs on August 20, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-05-20 | Date of the restricted stock unit grant transaction. |
| 2026-05-22 | Date the Form 4 was filed with the SEC. |
| 2026-08-20 | Scheduled date for the first vesting installment of the RSUs. |
| 2026-11-20 | Scheduled date for the second vesting installment of the RSUs. |
| 2027-02-20 | Scheduled date for the third vesting installment of the RSUs. |
| 2027-05-18 | Scheduled date for the final vesting installment of the RSUs. |
Recommendation
holdThis filing represents a routine compensation event for a director and does not provide new material information regarding the company's operational performance or strategic direction.
Keywords
Integer Holdings Corp, ITGR, Insider Trading, Form 4, Restricted Stock Units, Director Compensation, Aaron Kapito, Medical Device Manufacturing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.